CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the submission of ...
Pleural diseases affect the pleural tissue that lines the inside of the chest cavity and covers the outside of the lungs. The visceral pleura (which covers the lung) and the parietal pleura (which ...
Mount Sinai analysis looks at the effectiveness of electrocardiograms analyzed via deep learning as a tool for early COPD detection ...
A 40-year-old woman who was once accustomed to frequent travel suddenly found herself struggling to breathe after just a few ...
A quasi-experimental study found anticipatory nursing in chronic obstructive pulmonary disease lowered anxiety and depression ...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive-fibrosing interstitial lung disease of unknown origin that affects 3 million people worldwide and imparts substantial burdens to patients, ...
Meilan King Han, MD, a professor of internal medicine at the University of Michigan, discusses how her practice has altered patient care to adapt to the ongoing pandemic and challenges patients with ...
In 2025, respiratory news highlighted advances in lung imaging, expanded support for pulmonary rehabilitation and promising ...
Obstructive lung diseases like COPD cause trouble when you're exhaling air. Restrictive lung diseases like pulmonary fibrosis make it harder to inhale air, reducing total lung capacity. There are two ...
The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...
DUBLIN--(BUSINESS WIRE)--The "Global Lung Marker Market Report by Cancer Type, Marker Type, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering. The global lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback